Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

COVID-19 variant XFG accounted for 0% of U.S. cases in May. By late-June, it became the third-most common strain.

COUNT: Our inventory is one of our most valuable assets, and ensuring that we have an opinionated, data-driven view on its value and potential growth opportunities requires a rigorous enumeration and ...